CEO Interviews | The Wall Street Analyzer - Part 5

Latest News

[ March 25, 2025 ] Soligenix Announces Publication Demonstrating CiVax™ Booster Induces Rapid Broad Protection Against COVID-19 Variants News Feed
[ March 14, 2025 ] Kobrea Commissions Property-Wide Airborne Magnetic & Radiometric Survey at Western Malargüe Copper Projects, Mendoza Province, Argentina News Feed
[ March 6, 2025 ] HyBryte™ Treatment Studies Presented at Two Medical Conferences in March News Feed
[ February 19, 2025 ] Kobrea Completes Next Payment Under Property Option Agreement for its Western Malargue Copper Projects News Feed
[ February 12, 2025 ] Pasofino Gold Wins Top African Gold Project at the 2025 Mining Indaba Dealmakers Den News Feed
[ February 12, 2025 ] VSee Health Announces Contract with Top Kidney Care Provider to Add VSee Workflow to Oracle Cerner EHR News Feed
[ February 7, 2025 ] Greenlite Venture Signs Letter of Intent to Acquire TicketBash.com News Feed

Acutus Medical (NASDAQ: AFIB)

February 24, 2023 The Wall Street Analyzer Comments Off

Interview update with David Roman, CEO and President […]

CEO Interviews

Pro-Dex, Inc (NASDAQ: PDEX)

February 22, 2023 The Wall Street Analyzer Comments Off

Interview update with Rick Van Kirk, CEO
[…]

No Picture

Decibel Cannabis Company Inc. (TSXV: DB) (OTCQB: DBCCF)

February 22, 2023 The Wall Street Analyzer Comments Off

THIS INTERVIEW HAS EXPIRED

No Picture

Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP)

February 16, 2023 The Wall Street Analyzer Comments Off

THIS INTERVIEW HAS EXPIRED

No Picture

Castellum, Inc (NYSE American: CTM)

February 15, 2023 The Wall Street Analyzer Comments Off

Interview with Mark Fuller, CEO and President
[…]

No Picture

Candel Therapeutics (NASDAQ: CADL)

February 7, 2023 The Wall Street Analyzer Comments Off

THIS INTERVIEW HAS EXPIRED

CEO Interviews

Power Nickel Inc. (TSX-V: PNPN)(OTCQB:CMETF)

February 6, 2023 The Wall Street Analyzer Comments Off

THIS INTERVIEW HAS EXPIRED

No Picture

BuildDirect.com Technologies (TSXV: BILD)

February 6, 2023 The Wall Street Analyzer Comments Off

THIS INTERVIEW HAS EXPIRED

No Picture

Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF)

February 1, 2023 The Wall Street Analyzer Comments Off

THIS INTERVIEW HAS EXPIRED

No Picture

FingerMotion (NASDAQ: FNGR)

January 31, 2023 The Wall Street Analyzer Comments Off

THIS INTERVIEW HAS EXPIRED

Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com